Cargando…
Converting cancer mutations into therapeutic opportunities
While the use of synthetic lethality has been around for decades in model organism studies, it has only recently been applied to cancer therapy and judging by recent results, with great success. Following on a recent paper that demonstrates the clinical application of this strategy (Fong et al, 2009...
Autores principales: | O'Brien, Tom, Stokoe, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378146/ https://www.ncbi.nlm.nih.gov/pubmed/20049732 http://dx.doi.org/10.1002/emmm.200900044 |
Ejemplares similares
-
Mutations for the people
por: Kristensen, Vessela, et al.
Publicado: (2010) -
An acute phase protein ready to go therapeutic for sepsis
por: Vandevyver, Sofie, et al.
Publicado: (2014) -
A magic bullet to specifically eliminate mutated mitochondrial genomes from patients' cells
por: Moraes, Carlos T
Publicado: (2014) -
Novel non-coding RNA-based therapeutic approaches to prevent statin-induced liver damage
por: Bang, Claudia, et al.
Publicado: (2012) -
TNFα cleavage beyond TACE/ADAM17: matrix metalloproteinase 13 is a potential therapeutic target in sepsis and colitis
por: Becker-Pauly, Christoph, et al.
Publicado: (2013)